blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2803357

EP2803357 - Angiogenesis inhibitors [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  24.09.2021
Database last updated on 11.09.2024
FormerThe patent has been granted
Status updated on  16.10.2020
FormerGrant of patent is intended
Status updated on  21.07.2020
FormerExamination is in progress
Status updated on  22.09.2017
Most recent event   Tooltip14.06.2024Lapse of the patent in a contracting state
New state(s): TR		published on 17.07.2024  [2024/29]
Applicant(s)For all designated states
THE JOHNS-HOPKINS UNIVERSITY
3400 North Charles Street
Baltimore, MD 21218 / US
[2014/47]
Inventor(s)01 / Liu, Jun
6909 Sandy Creek Court
Clarksville, MD 21029 / US
02 / Chong, Curtis
Reed Hall 4D2
Baltimore, MD 21205 / US
03 / Sullivan, David
117 Hawthorn Road
Baltimore, MD 21210 / US
 [2014/47]
Representative(s)Ladendorf, Oliver
Kraus & Weisert
Patentanwälte PartGmbB
Thomas-Wimmer-Ring 15
80539 München / DE
[2014/47]
Application number, filing date14169291.327.06.2005
[2014/47]
Priority number, dateUS20040583076P25.06.2004         Original published format: US 583076 P
[2014/47]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP2803357
Date:19.11.2014
Language:EN
[2014/47]
Type: A3 Search report 
No.:EP2803357
Date:25.02.2015
Language:EN
[2015/09]
Type: B1 Patent specification 
No.:EP2803357
Date:18.11.2020
Language:EN
[2020/47]
Search report(s)(Supplementary) European search report - dispatched on:EP23.01.2015
ClassificationIPC:A61K31/496, A61P35/00, A61P35/02, A61P19/02, A61P27/02, A61P29/00, A61P17/00, A61P17/02, A61P17/06, A61P17/10, A61P17/12, A61K38/50, A61K31/365, A61K31/4164, A61K31/47, A61K31/58, A61K31/7072, A61P31/00, A61P31/04, A61K31/4196
[2020/33]
CPC:
A61K31/58 (EP,US); A61F9/0008 (US); A61F9/0017 (US);
A61K31/00 (EP,US); A61K31/365 (EP,US); A61K31/4164 (EP,US);
A61K31/4196 (EP,US); A61K31/47 (EP,US); A61K31/496 (EP,US);
A61K31/7072 (EP,US); A61K38/50 (EP,US); A61K45/06 (US);
A61P17/00 (EP); A61P17/02 (EP); A61P17/06 (EP);
A61P17/10 (EP); A61P17/12 (EP); A61P19/02 (EP);
A61P27/02 (EP); A61P29/00 (EP); A61P31/00 (EP);
A61P31/04 (EP); A61P31/10 (EP); A61P31/12 (EP);
A61P31/22 (EP); A61P35/00 (EP); A61P35/02 (EP);
Y02A50/30 (EP,US) (-)
Former IPC [2020/32]A61K31/496, A61P35/00, A61P35/02, A61P19/02, A61P27/02, A61P29/00, A61P17/00, A61P17/02, A61P17/06, A61P17/10, A61P17/12
Former IPC [2020/31]A61K31/496, A61P19/02, A61P27/02, A61P29/00, A61P17/00, A61P35/00, A61K45/06, A61K31/58, A61K38/50, A61K31/365, A61K31/4164, A61K31/4196, A61K31/47, A61P17/02, A61P17/06, A61P17/10, A61P17/12
Former IPC [2014/47]A61K31/496, A61K31/58, A61K45/06, A61P35/00, A61P17/00, A61P29/00, A61P27/02, A61P19/02
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2015/41]
Former [2014/47]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  MC,  NL,  PL,  PT,  RO,  SE,  SI,  SK,  TR 
TitleGerman:Angiogenesehemmer[2014/47]
English:Angiogenesis inhibitors[2014/47]
French:Inhibiteurs d'angiogenèse[2014/47]
Examination procedure25.08.2015Amendment by applicant (claims and/or description)
25.08.2015Examination requested  [2015/41]
20.09.2017Despatch of a communication from the examining division (Time limit: M06)
02.05.2018Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
04.05.2018Reply to a communication from the examining division
01.08.2019Despatch of a communication from the examining division (Time limit: M06)
11.02.2020Reply to a communication from the examining division
22.07.2020Communication of intention to grant the patent
07.10.2020Fee for grant paid
07.10.2020Fee for publishing/printing paid
07.10.2020Receipt of the translation of the claim(s)
Parent application(s)   TooltipEP05787846.4  / EP1765336
Opposition(s)19.08.2021No opposition filed within time limit [2021/43]
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the examination report
04.05.2018Request for further processing filed
04.05.2018Full payment received (date of receipt of payment)
Request granted
16.05.2018Decision despatched
Fees paidRenewal fee
21.05.2014Renewal fee patent year 03
21.05.2014Renewal fee patent year 04
21.05.2014Renewal fee patent year 05
21.05.2014Renewal fee patent year 06
21.05.2014Renewal fee patent year 07
21.05.2014Renewal fee patent year 08
21.05.2014Renewal fee patent year 09
21.05.2014Renewal fee patent year 10
29.06.2015Renewal fee patent year 11
27.06.2016Renewal fee patent year 12
27.06.2017Renewal fee patent year 13
27.06.2018Renewal fee patent year 14
27.06.2019Renewal fee patent year 15
29.06.2020Renewal fee patent year 16
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU27.06.2005
AT18.11.2020
CY18.11.2020
CZ18.11.2020
DK18.11.2020
EE18.11.2020
ES18.11.2020
FI18.11.2020
IT18.11.2020
LT18.11.2020
MC18.11.2020
NL18.11.2020
PL18.11.2020
RO18.11.2020
SE18.11.2020
SI18.11.2020
SK18.11.2020
TR18.11.2020
BG18.02.2021
GR19.02.2021
IS18.03.2021
PT18.03.2021
GB27.06.2021
IE27.06.2021
LU27.06.2021
BE30.06.2021
CH30.06.2021
FR30.06.2021
LI30.06.2021
[2024/29]
Former [2023/29]HU27.06.2005
AT18.11.2020
CY18.11.2020
CZ18.11.2020
DK18.11.2020
EE18.11.2020
ES18.11.2020
FI18.11.2020
IT18.11.2020
LT18.11.2020
MC18.11.2020
NL18.11.2020
PL18.11.2020
RO18.11.2020
SE18.11.2020
SI18.11.2020
SK18.11.2020
BG18.02.2021
GR19.02.2021
IS18.03.2021
PT18.03.2021
GB27.06.2021
IE27.06.2021
LU27.06.2021
BE30.06.2021
CH30.06.2021
FR30.06.2021
LI30.06.2021
Former [2023/24]AT18.11.2020
CY18.11.2020
CZ18.11.2020
DK18.11.2020
EE18.11.2020
ES18.11.2020
FI18.11.2020
IT18.11.2020
LT18.11.2020
MC18.11.2020
NL18.11.2020
PL18.11.2020
RO18.11.2020
SE18.11.2020
SI18.11.2020
SK18.11.2020
BG18.02.2021
GR19.02.2021
IS18.03.2021
PT18.03.2021
GB27.06.2021
IE27.06.2021
LU27.06.2021
BE30.06.2021
CH30.06.2021
FR30.06.2021
LI30.06.2021
Former [2022/34]AT18.11.2020
CZ18.11.2020
DK18.11.2020
EE18.11.2020
ES18.11.2020
FI18.11.2020
IT18.11.2020
LT18.11.2020
MC18.11.2020
NL18.11.2020
PL18.11.2020
RO18.11.2020
SE18.11.2020
SI18.11.2020
SK18.11.2020
BG18.02.2021
GR19.02.2021
IS18.03.2021
PT18.03.2021
GB27.06.2021
IE27.06.2021
LU27.06.2021
BE30.06.2021
CH30.06.2021
FR30.06.2021
LI30.06.2021
Former [2022/23]AT18.11.2020
CZ18.11.2020
DK18.11.2020
EE18.11.2020
ES18.11.2020
FI18.11.2020
IT18.11.2020
LT18.11.2020
MC18.11.2020
NL18.11.2020
PL18.11.2020
RO18.11.2020
SE18.11.2020
SI18.11.2020
SK18.11.2020
BG18.02.2021
GR19.02.2021
IS18.03.2021
PT18.03.2021
GB27.06.2021
IE27.06.2021
LU27.06.2021
CH30.06.2021
FR30.06.2021
LI30.06.2021
Former [2022/22]AT18.11.2020
CZ18.11.2020
DK18.11.2020
EE18.11.2020
ES18.11.2020
FI18.11.2020
IT18.11.2020
LT18.11.2020
MC18.11.2020
NL18.11.2020
PL18.11.2020
RO18.11.2020
SE18.11.2020
SI18.11.2020
SK18.11.2020
BG18.02.2021
GR19.02.2021
PT18.03.2021
GB27.06.2021
IE27.06.2021
LU27.06.2021
CH30.06.2021
LI30.06.2021
Former [2022/21]AT18.11.2020
CZ18.11.2020
DK18.11.2020
EE18.11.2020
ES18.11.2020
FI18.11.2020
IT18.11.2020
LT18.11.2020
MC18.11.2020
NL18.11.2020
PL18.11.2020
RO18.11.2020
SE18.11.2020
SI18.11.2020
SK18.11.2020
BG18.02.2021
GR19.02.2021
PT18.03.2021
IE27.06.2021
LU27.06.2021
CH30.06.2021
LI30.06.2021
Former [2022/18]AT18.11.2020
CZ18.11.2020
DK18.11.2020
EE18.11.2020
ES18.11.2020
FI18.11.2020
IT18.11.2020
LT18.11.2020
MC18.11.2020
NL18.11.2020
PL18.11.2020
RO18.11.2020
SE18.11.2020
SI18.11.2020
SK18.11.2020
BG18.02.2021
GR19.02.2021
PT18.03.2021
LU27.06.2021
Former [2022/10]AT18.11.2020
CZ18.11.2020
DK18.11.2020
EE18.11.2020
ES18.11.2020
FI18.11.2020
IT18.11.2020
LT18.11.2020
MC18.11.2020
NL18.11.2020
PL18.11.2020
RO18.11.2020
SE18.11.2020
SI18.11.2020
SK18.11.2020
BG18.02.2021
GR19.02.2021
PT18.03.2021
Former [2022/08]AT18.11.2020
CZ18.11.2020
DK18.11.2020
EE18.11.2020
ES18.11.2020
FI18.11.2020
IT18.11.2020
LT18.11.2020
MC18.11.2020
NL18.11.2020
PL18.11.2020
RO18.11.2020
SE18.11.2020
SI18.11.2020
SK18.11.2020
BG18.02.2021
GR19.02.2021
IS18.03.2021
PT18.03.2021
Former [2021/51]AT18.11.2020
CZ18.11.2020
DK18.11.2020
EE18.11.2020
ES18.11.2020
FI18.11.2020
IT18.11.2020
LT18.11.2020
NL18.11.2020
PL18.11.2020
RO18.11.2020
SE18.11.2020
SI18.11.2020
SK18.11.2020
BG18.02.2021
GR19.02.2021
IS18.03.2021
PT18.03.2021
Former [2021/49]AT18.11.2020
CZ18.11.2020
DK18.11.2020
EE18.11.2020
FI18.11.2020
IT18.11.2020
LT18.11.2020
NL18.11.2020
PL18.11.2020
RO18.11.2020
SE18.11.2020
SI18.11.2020
SK18.11.2020
BG18.02.2021
GR19.02.2021
IS18.03.2021
PT18.03.2021
Former [2021/48]AT18.11.2020
CZ18.11.2020
DK18.11.2020
EE18.11.2020
FI18.11.2020
IT18.11.2020
LT18.11.2020
NL18.11.2020
PL18.11.2020
RO18.11.2020
SE18.11.2020
SK18.11.2020
BG18.02.2021
GR19.02.2021
IS18.03.2021
PT18.03.2021
Former [2021/46]AT18.11.2020
CZ18.11.2020
DK18.11.2020
EE18.11.2020
FI18.11.2020
LT18.11.2020
NL18.11.2020
PL18.11.2020
RO18.11.2020
SE18.11.2020
SK18.11.2020
BG18.02.2021
GR19.02.2021
IS18.03.2021
PT18.03.2021
Former [2021/37]AT18.11.2020
CZ18.11.2020
DK18.11.2020
EE18.11.2020
FI18.11.2020
LT18.11.2020
PL18.11.2020
RO18.11.2020
SE18.11.2020
SK18.11.2020
BG18.02.2021
GR19.02.2021
IS18.03.2021
PT18.03.2021
Former [2021/36]AT18.11.2020
CZ18.11.2020
EE18.11.2020
FI18.11.2020
LT18.11.2020
PL18.11.2020
RO18.11.2020
SE18.11.2020
SK18.11.2020
BG18.02.2021
GR19.02.2021
IS18.03.2021
PT18.03.2021
Former [2021/35]AT18.11.2020
CZ18.11.2020
FI18.11.2020
LT18.11.2020
PL18.11.2020
RO18.11.2020
SE18.11.2020
SK18.11.2020
BG18.02.2021
GR19.02.2021
IS18.03.2021
PT18.03.2021
Former [2021/34]AT18.11.2020
CZ18.11.2020
FI18.11.2020
LT18.11.2020
PL18.11.2020
SE18.11.2020
BG18.02.2021
GR19.02.2021
IS18.03.2021
PT18.03.2021
Former [2021/33]AT18.11.2020
FI18.11.2020
LT18.11.2020
PL18.11.2020
SE18.11.2020
BG18.02.2021
GR19.02.2021
IS18.03.2021
PT18.03.2021
Former [2021/25]AT18.11.2020
FI18.11.2020
PL18.11.2020
SE18.11.2020
BG18.02.2021
GR19.02.2021
IS18.03.2021
PT18.03.2021
Former [2021/24]AT18.11.2020
FI18.11.2020
SE18.11.2020
BG18.02.2021
GR19.02.2021
PT18.03.2021
Former [2021/23]FI18.11.2020
SE18.11.2020
GR19.02.2021
PT18.03.2021
Former [2021/21]FI18.11.2020
PT18.03.2021
Former [2021/20]FI18.11.2020
Documents cited:Search[A]US2004092740  (DUMAS JACQUES P [US], et al) [A] 1-14 * page 1, paragraph 1 * * claims 4, 5 *;
 [A]US2004067985  (HAVIV FORTUNA [US], et al) [A] 1-14 * page 1, paragraph 1 * * page 6, paragraph 110 - paragraph 112 * * claims 25-27 *;
 [XP]WO2004105696  (COMBINATORX INC [US], et al) [XP] 1-6,11-14 * claims 3-6, 8, 9 *;
 [XP]WO2005000208  (COMBINATORX INC [US], et al) [XP] 1-6,11-14 * claims 3-5, 7, 8 *;
 [XI]WO03092617  (COMBINATORX INC [US], et al) [X] 1-5,11,12 * claims 19, 23, 26 * [I] 7-10;
 [XI]WO9920271  (ROC SA [FR], et al) [X] 1-4,11,12 * claims 2, 4, 5, 6 * * page 5, line 12 - line 14 * [I] 7-10
ExaminationUS2002193384
 US2003161893
 BE1004029
    - BRALIPISUT ASADAMONGKOL ET AL, "The development of hyperbaric oxygen therapy for skin rejuvenation and treatment of photoaging", MEDICAL GAS RESEARCH, BIOMED CENTRAL LTD, LONDON, UK, (20140401), vol. 4, no. 1, doi:10.1186/2045-9912-4-7, ISSN 2045-9912, page 7, XP021184070

DOI:   http://dx.doi.org/10.1186/2045-9912-4-7
by applicantUS2005137583
 US2004219181
 US2004265356
 US2005031669
 US2005137538
 US2002086051
 US2002106395
 US2002110591
 US2002110592
 US2002110635
 US5378475
 US5773019
 US5902598
 US6001386
 US6726918
 US6331313
 US5824072
 US5632984
 US6217895
 US6375972
 US5807876
 US4680285
 US4451648
 US3870790
 US4226859
 US4369172
 US4842866
 US5705190
 US6638534
 US5541171
 US5217720
 US6569457
 US6756058
 US2005096290
 US2005126948
    - FOLLANAN, J., N. ENGL. J. MED., (1971), vol. 285, pages 1182 - 1186
    - HANAHAN, D.; FOLKMAN, J., CELL, (1996), vol. 86, pages 353 - 364
    - FOLKMAN, J.; KLAGSBRUN, M., SCIENCE, (1987), vol. 235, pages 442 - 447
    - CARMELIET, P., NAT. MED., (2003), vol. 9, pages 653 - 660
    - PANKIEWICZ ET AL., PHARMACOL THER., (1997), vol. 76, no. 1-3, pages 89 - 100
    - PANKIEWICZ ET AL., J MED CHEM., (2002), vol. 45, no. 3, pages 703 - 12
    - MOHACSI, P. J.; TULLER, D.; HULLIGER, B.; WIJNGAARD, P. L., J. HEART. LUNG. TRANSPLANT., (1997), vol. 16, pages 484 - 492
    - EUGUI, E. M.; ALMQUIST, S. J.; MULLER, C. D.; ALLISON, A. C., SCAND. J. IMMUNOL., (1991), vol. 33, pages 161 - 173
    - ROCHE LABORATORIES, (2003), vol. 1, pages 1 - 34
    - CARTER, S. B.; FRANKLIN, T. J.; JONES, D. F.; LEONARD, B. J.; MILLS, S. D.; TURNER, R. W.; TURNER, W. B., NATURE, (1969), vol. 223, pages 848 - 850
    - KNUDTZON, S.; NISSEN, N. 1., CANCER CHEMOTHER. REP., (1972), vol. 56, pages 221 - 227
    - BREWIN, T. B.; COLE, M. P.; JONES, C. T.; PLATT, D. S.; TODD, I. D., CANCER CHEMOTHER. REP., (1972), vol. 56, pages 83 - 87
    - KNUDTZON, S.; NISSEN, N. 1., CANCER CHEMOTHER. REP., (1972), vol. 56, pages 221 - 22
    - KNUDTZON; S.; NISSEN, N. I., CANCER CHEMOTHER. REP., (1972), vol. 56, pages 221 - 227
    - BREWIN, T. B.; COLE, M. .; JONES, C. T.; PLATT, D. S.; TODD, I. D., CANCER CHEMOTHER. REP., (1972), vol. 56, pages 83 - 87
    - GU, J. J.; STEGMANN, S.; GATHY, K.; MURRAY, R; LALIBERTE, J.; AYSCUE, L.; MITCHELL, B. S., J. CLIN. INVEST., (2000), vol. 106, pages 599 - 606
    - GU, J. J.; TOLIN, A. K.; JAIN, J.; HUANG, H.; SANTIAGO, L.; MITCHELL, B. S., MOL. CELL. BIOL., (2003), vol. 23, pages 6702 - 6712
    - LEE, H. J.; PAWLAK, K.; NGUYEN, B. T.; ROBINS, R K.; SADEE, W., CANCER RES., (1985), vol. 45, pages 5512 - 5520
    - SINTCHAK, M. D.; NIMMESGERN, E., IMMUNOPHARMACOLOGY, (2000), vol. 47, pages 163 - 184
    - ALEXANDER, J. ET AL., JOUNIAL OF MEDICINAL CHEMISTRY, (1988), vol. 31, pages 318 - 322
    - BUNDGAARD, H., Design of Prodrugs, ELSEVIER, (1985), pages 1 - 92
    - BUNDGAARD, H.; NIELSEN, N. M., JOURNAL OF MEDICINAL CHEMISTRY, (1987), vol. 30, pages 451 - 454
    - BUNDGAARD, H., A Textbook ofDrug Design and Development, HARWOOD ACADEMIC PUBL., (1991), pages 113 - 191
    - DIGENIS, G. A. ET AL., Handbook of Experimental Pharmacology, (1975), vol. 28, pages 86 - 112
    - FRIIS, G. J.; BUNDGAARD, H., A Textbook of Drug Design and Development; 2 ed., OVERSEAS PUBL., (1996), pages 351 - 385
    - PITMAN, I. H., MEDICINAL RESEARCH REVIEWS, (1981), vol. 1, pages 189 - 214
    - PAN, F.; YE, Z.; CHENG, L.; LIU, J. O., J. BIOL. CHEM., (2004), vol. 279, pages 14477 - 14480
    - DREVS, J.; HOFMANN, I.; HUGENSCHMIDT, H.; WITTIG, C.; MADJAR, H; MULLER, M.; WOOD, J.; MARTINY-BARON, G.; UNGER, C.; MARME, D., CANCER RES., (2000), vol. 60, pages 4819 - 4824
    - LIPSKY, J. J., LANCET, (1996), vol. 348, pages 1357 - 1359
    - ALLISON, A. C.; EUGUI, E. M., IMMUNOPHARMACOLOGY, (2000), vol. 47, pages 85 - 118
    - LALIBERTE, J.; YEE, A.; XIONG, Y.; MITCHELL, B. S., BLOOD, (1998), vol. 91, pages 2896 - 2904
    - COLLART, F. R; CHUBB, C. B.; MIRKIN, B. L.; HUBERMAN, E., CANCER RES., (1992), vol. 52, pages 5826 - 5828
    - SENDA, M.; NATSUMEDA, Y., LIFE SCI., (1994), vol. 54, pages 1917 - 1926
    - LOIS, C.; HONG, E. J.; PEASE, S.; BROWN, E. J.; BALTIMORE, D., SCIENCE, (2002), vol. 295, pages 868 - 872
    - VAN LEEUWEN, L.; GUIFFRE, A. K.; SEWELL, W. A.; VOS, B. J.; RAINER, S.; ATKINSON, K., TRANSPLANTATION, (1997), vol. 64, pages 1097 - 1101
    - FAHMY, R. G.; DASS, C. R.; SUN, L. Q.; CHESTERMAN, C. N.; KHACBIGIAN, L. M., NAT. MED., (2003), vol. 9, pages 1026 - 1032
    - FAHMY, R G.; DASS, C. R.; SUN, L Q.; CHESTERMAN, C. N.; KHACHIGIAN, L. M., NAT. MED., (2003), vol. 9, pages 1026 - 1032
    - TRESSLER, R. J.; GARVIN, L. J.; SLATE, D. L., INT. J. CANCER, (1994), vol. 57, pages 568 - 573
    - SALUP, R. R.; WILTROUT, R. H., CANCER RES., (1986), vol. 46, pages 3358 - 3363
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.